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Abstract
Lymphangiosarcoma following breast cancer is a relatively rare entity, with around 300 cases so far
reported worldwide. Affecting the long term survivors of breast cancer, lymphangiosarcoma
(Stewart-Traves Syndrome) has a high mortality rate. Since lympedema following radical mastectomy
or axillary clearance and radiotherapy seems to be the main predisposing factor, further research
regarding modifications in the surgical technique of axillary nodes dissection as well as the
development of new chemotherapeutic agents effective in lymphangiosarcoma are required.
Introduction
Lymphangiosarcoma following breast cancer is a rare
entity. Around 300 cases have been reported worldwide
since Stewart-Traves syndrome characterized by angio
sarcoma of skin and soft tissue of the area after Radical
Mastectomy, Radiation and Lymphedema [1]. Its inci-
dence in white American women is estimated to be 1.6 per
100,000 with only 25% of these sarcomas originating in
the upper limb [2]. Lymphangiosarcoma is characterized
by skin changes in the form of purple colored raised
cutaneous lesions progressing to ulceration in a lymphe-
dematous arm within a median of ten years following
mastectomy [3]. Lymphangiosarcoma has a poor prog-
nosis [4,5], with a 5 year survival of <5% with multi-
modality treatment. Wide surgical resection is the
treatment of choice [4,6]. Several hypotheses have been
postulated about its pathogenic mechanism. Lymphatic
blockage, resulting in stimuli for growth factors and
cytokines with a consequent proliferation of vessels
and lymphatics is one hypothesis that explains the
proliferation of lymphatic vessels in the affected edema-
tous tissue [7]. The role of radiotherapy in the develop-
ment of lymphangiosarcoma is questionable because
most post radiation chest wall sarcomas are not lymphan-
giosarcomas [8]. Review of literature suggests that mas-
tectomy resulting in Breast Cancer Related Lymphedema
(BCRL) is the main predisposing factor [8]. Other factors
such as cardiovascular diseases and hypertension have also
been described in relation to lymphangiosarcoma.
Case presentation
A 74-year-old lady with a history of hypertension and
known case of breast cancer presented to our clinic with a
swelling of the left proximal arm for the past three years.
Patient was of Punjabi by ethnicity and was a Pakistani
national.
She had under gone a modified radical mastectomy
(MRM) 16 years ago in 1990 for infiltrating ductal
carcinoma of the left breast, received 25 fractions of
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radiotherapy, followed by Tamoxifen for five years. The
patient had a history of gradual increase in the size of the
swelling upper arm and complained of non-radiating, mild
to moderate pain with appearance of nodular lesions
along antero medial aspect of upper arm (Figure 1); that
had ulcerated in the proceeding 8 weeks. There was no
history of fever, numbness and paresthesias in the left
upper limb. On examination the patient was afebrile;
with lymphedema of entire left arm. A 12 × 6 cm area of
multiple ulcerated lesions with surrounding erythema and
induration and absence of deep infiltration was noted.
Motor power and range of motion was normal both at
the elbow and shoulder joint. Biopsy from the mass
confirmed the diagnosis of lymphangiosarcoma (Figures 2
and 3). A lymphovascular invasive pattern was seen and
immunohistochemistry was positive for endothelial cell
markers (Figure 4) (CD 31–CD36). There was no evidence
of distant metastasis on metastatic workup. CXR showed
bilateral pleural thickening more marked on the left side.
CT scan of chest revealed thickening of the skin overlying
the mass and non specific ground glass appearance in the
upper lung fields bilaterally. No active pulmonary lesion
was seen. Ultrasound liver and gallbladder was also
normal. MRI showed a soft tissue mass occupying the
medial side of the left upper arm with evidence of
extension through the sub-coetaneous tissue and up to
the muscle layer with enhancement (Figure 5), with
absence of osseous disease on bone scan. Disarticulation
of the left shoulder joint was performed successfully. The
patient developed metastases in the brain and lungs
5 months after the procedure and expired a month later.
Discussion
Currently there are 2 million breast cancer survivors in the
United States alone and 20% of them suffer from Breast
Cancer Related Lymphedema [9]. Advances in diagnostic
aids, discoveries of newer chemotherapeutic agents and
achievements of excellence in the field of surgery has
offered substantial improvement in long term survival.
This, however over the last 7 decades has been coupled with
increasing number of complications as reported in literature
[10]. BCRL leading to lymphangiosarcoma is one such rare
complication. With an incidence of 10% it is estimated that
United States alone will have 200,000 new cases of BCRL
diagnosed every year [11,12]. Numerous studies have
implicated lack of awareness (both on the part of the
surgeon/physician and patient) in the ever increasing
numbers of breast cancer survivors being diagnosed with
Figure 1. Image of the patient’s left arm showing a 10 × 12 cm
lesion on the ulnar aspect of the arm.
Figure 2. A low power view 20× magnification showing thin
walled vascular channels lined by endothelial cells.
Figure 3. 40× magnification showing vascular channels lined
by endothelial calls showing nuclear atypia and pleomorphism.
The surrounding stroma is loose and myxoid.
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BCRL [10,11,13]. Lack of consensus on the diagnostic
criteria also seems to be one factor affecting an early
diagnosis of this entity [11]. Although in majority of the
cases reported so far postmastectomy, complete axillary
node dissection and radiotherapy seem to be the risk factors
for developing BCRL progressing to lymphangiosarcoma,
there have also been reports of idiopathic lymphedema
related to lymphangiosarcoma as well [4,14].
Strategies to decrease chronic lymphedema include man-
ual and sequential pneumatic lymphatic compression
[15,16], periodic examination [17], modification of the
surgical technique [12], manual lymph drainage, compres-
sion garments, prescribed exercises and ultrasound
therapy. More recently, use of Coumarin, intra-arterial
injections of autologous lymphocytes, liposuction,
Selenium, and laser treatment are also reported [16].
Advocated management of lymphangiosarcoma includes
early diagnosis and radical surgical resection [6,8]. How-
ever, other promising options that need to be explored
further, include radio-immunotherapy (54 Gy/Interferon
beta) [18], doxorubicin which has shown promising
results both in animal models and humans [19], isolated
limb perfusion (ILP) tumor necrosis factor (TNF) and
melphalan. Early diagnosis and conservative surgery of
breast and axilla, has offered remarkable reduction
incidence of lymphedema. Total preservation of axillary
lymphatic with advent and extension of sentinel node
biopsy, would further reduce this complication.
Conclusion
Stewart-Traves syndrome is a rare entity with poor
response to chemo therapy. Awareness about the pathol-
ogy and its preceding sign & symptoms among both
physicians and breast cancer survivors will ensure regular
long term follow up resulting in an early diagnosis. Since
lympedema following radical mastectomy or axillary
clearance and radiotherapy seems to be the main predis-
posing factor, further research regarding modifications in
the surgical technique of axillary nodes dissection as well
as the development of new chemotherapeutic agents
effective in Lymphangiosarcoma are required.
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